North Chicago, IL, United States of America

Michelle L Hastings

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Lake Bluff, IL (US) (2014 - 2017)
  • North Chicago, IL (US) (2016 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovator Michelle L Hastings: Pioneering Research in Genetic Therapy

Introduction

Michelle L Hastings, a prominent inventor based in North Chicago, IL, has made significant contributions to the field of genetic therapy. With an impressive portfolio of 13 patents, Hastings focuses on developing innovative compounds to address critical medical conditions, including cystic fibrosis and Alzheimer’s disease. Her work exemplifies the intersection of science and technology in the pursuit of transformative healthcare solutions.

Latest Patents

Hastings’ latest patents showcase her dedication to advancing genetic therapies. One notable patent involves "Antisense compounds targeting genes associated with cystic fibrosis." This innovation comprises oligonucleotides that are complementary to the cystic fibrosis transmembrane conductance regulator (CFTR) RNA transcript. These compounds have the potential to hybridize with the CFTR RNA transcript within cells, leading to the modulation of splicing and, ultimately, providing therapeutic benefits for symptoms related to cystic fibrosis.

Another recent patent details "Compounds and methods for the modulation of amyloid-β precursor protein." This invention focuses on modulating the expression of amyloid precursor protein (APP). By altering the splicing of APP, Hastings’ research aims to reduce the production of amyloid β, a crucial aspect in developing treatments for Alzheimer’s disease.

Career Highlights

Throughout her career, Hastings has contributed significantly to medical research and innovation. She has worked with prestigious institutions such as Rosalind Franklin University of Medicine and Science and McLean Hospital Corporation. Her endeavors in these organizations have allowed her to collaborate with leading experts in her field and expand her knowledge and expertise.

Collaborations

Hastings has collaborated with noteworthy colleagues including Ole Isacson and Joanna A Korecka-Roet. These collaborations have fostered an environment of innovation and research excellence, contributing to Hastings' success as an inventor and researcher in the realm of genetic therapy.

Conclusion

In summary, Michelle L Hastings stands out as a pioneering inventor in the field of genetic therapy. Her latest patents and significant career milestones reflect her commitment to addressing critical health issues through innovative solutions. As her research continues to evolve, Hastings remains a vital contributor to advancements that could transform the treatment and management of genetic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…